Viewing Study NCT06531018


Ignite Creation Date: 2025-12-25 @ 4:49 AM
Ignite Modification Date: 2026-03-02 @ 4:12 AM
Study NCT ID: NCT06531018
Status: RECRUITING
Last Update Posted: 2025-02-18
First Post: 2024-07-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.
Sponsor: Renata PLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module